Asia-Pacific Single-Cell Multi Omics Market: Analysis and Forecast, 2023-2033
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
This report will be delivered in 1-5 working days.
Introduction to Asia-Pacific Single-Cell Multi-Omics Market
The Asia-Pacific single-cell multi-omics market is projected to reach $1.85 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 20.00% during the forecast period 2023-2033. The market is growing owing to various factors, such as the rising use of single-cell RNA sequencing (Sc-RNA) in large-scale genomics studies, a transition toward personalized medicine employing the single-cell multi-omics approach for disease screening and diagnostics, and increased uptake of single-cell multi-omics in drug development.
Market Introduction
The Asia-Pacific (APAC) single-cell multi-omics market is experiencing notable growth, driven by several key factors. This includes the increasing adoption of single-cell multi-omics technologies in genomics studies across the region. As personalized medicine gains prominence, there's a growing shift towards utilizing single-cell multi-omics approaches for disease screening and diagnostics. Moreover, the APAC region is witnessing a rising trend in the application of single-cell multi-omics in drug development processes. Government initiatives supporting genomic research and advancements in healthcare infrastructure further contribute to market growth. With a vast population and increasing focus on precision medicine, the APAC single-cell multi-omics market presents promising opportunities for research institutions, pharmaceutical companies, and healthcare providers to enhance understanding of diseases and develop targeted therapies tailored to individual patients.
Market Segmentation:
Segmentation 1: by Country
Growth/Marketing Strategy: The APAC single-cell multi-omics market has seen major development by key players operating in the market, such as new offerings, partnerships, collaboration, and joint ventures.
Competitive Strategy: The APAC single-cell multi-omics market has witnessed growth in recent years; as the field of single-cell multi-omics grows, it has witnessed increased collaboration between researchers, academic institutions, and industry partners to drive innovation and commercialization of these technologies. Single-cell multi-omics technologies are already being used in various applications, such as cancer research, immunology, and neuroscience. As the technologies continue to improve, they may be applied to other areas of research, such as developmental biology and stem cell research.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.
Some prominent names established in this market are:
This report will be delivered in 1-5 working days.
Introduction to Asia-Pacific Single-Cell Multi-Omics Market
The Asia-Pacific single-cell multi-omics market is projected to reach $1.85 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 20.00% during the forecast period 2023-2033. The market is growing owing to various factors, such as the rising use of single-cell RNA sequencing (Sc-RNA) in large-scale genomics studies, a transition toward personalized medicine employing the single-cell multi-omics approach for disease screening and diagnostics, and increased uptake of single-cell multi-omics in drug development.
Market Introduction
The Asia-Pacific (APAC) single-cell multi-omics market is experiencing notable growth, driven by several key factors. This includes the increasing adoption of single-cell multi-omics technologies in genomics studies across the region. As personalized medicine gains prominence, there's a growing shift towards utilizing single-cell multi-omics approaches for disease screening and diagnostics. Moreover, the APAC region is witnessing a rising trend in the application of single-cell multi-omics in drug development processes. Government initiatives supporting genomic research and advancements in healthcare infrastructure further contribute to market growth. With a vast population and increasing focus on precision medicine, the APAC single-cell multi-omics market presents promising opportunities for research institutions, pharmaceutical companies, and healthcare providers to enhance understanding of diseases and develop targeted therapies tailored to individual patients.
Market Segmentation:
Segmentation 1: by Country
- China
- Japan
- India
- Australia
- Singapore
- Rest-of-Asia-Pacific
Growth/Marketing Strategy: The APAC single-cell multi-omics market has seen major development by key players operating in the market, such as new offerings, partnerships, collaboration, and joint ventures.
Competitive Strategy: The APAC single-cell multi-omics market has witnessed growth in recent years; as the field of single-cell multi-omics grows, it has witnessed increased collaboration between researchers, academic institutions, and industry partners to drive innovation and commercialization of these technologies. Single-cell multi-omics technologies are already being used in various applications, such as cancer research, immunology, and neuroscience. As the technologies continue to improve, they may be applied to other areas of research, such as developmental biology and stem cell research.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.
Some prominent names established in this market are:
- BGI Group
- Shilps Sciences
- Takara Bio Inc.
Executive Summary
Scope of the Study
Research Methodology
1 MARKET
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.2 Market Overview
1.2.1 Key Findings
1.2.2 Current Market Scenario
1.2.2.1 For Researchers
1.2.2.2 For Diagnostics
1.3 Industry Outlook
1.3.1 Regulatory Framework
1.3.2 Patent Analysis
1.3.2.1 Awaited Technological Developments
1.3.2.2 Patent Filing Trend (by Country)
1.3.2.3 Patent Filing Trend (by Year)
1.3.3 Key Trends
1.3.3.1 Advancements in Imaging Techniques for Single-Cell Sequencing
1.3.3.2 Use of Artificial Intelligence (AI) and Machine Learning (ML) in Single-Cell Multi-Omics
1.3.3.3 Increased Development of Advanced Solution Based on Single-Cell Technology
1.3.4 Opportunity Assessment
1.3.5 Product Benchmarking
1.3.6 Clinical Trials
1.4 COVID-19 Impact
1.4.1 Pre-COVID-19
1.4.2 During COVID-19
1.4.3 Post COVID-19
1.5 Business Dynamics
1.5.1 Impact Analysis
1.5.2 Business Drivers
1.5.2.1 Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (Sc-RNA)
1.5.2.2 Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
1.5.2.3 Increasing Use of Single-Cell Multi-Omics for Drug Development
1.5.2.4 Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics
1.5.3 Business Restraints
1.5.3.1 High Cost of Single-Cell Analysis and Sequencing
1.5.3.2 Limited Availability of Large Online Data Storage and Analysis Platforms
1.5.4 Business Opportunities
1.5.4.1 Expansion into New Research Applications, Such as Single-Cell Metabolomics
1.5.4.2 Increasing Adoption of Genomic-Based Medicine in Emerging Nations
2 SINGLE-CELL MULTI-OMICS MARKET (BY REGION)
2.1 Asia-Pacific
2.1.1 Key Findings and Opportunity Assessment
2.1.2 Market Dynamics
2.1.2.1 Impact Analysis
2.1.3 Sizing and Forecast Analysis
2.1.3.1 Asia-Pacific Single-Cell Multi-Omics Market (by Country)
2.1.3.1.1 China
2.1.3.1.2 Japan
2.1.3.1.3 India
2.1.3.1.4 Singapore
2.1.3.1.5 Australia
2.1.3.1.6 Rest-of-Asia-Pacific
3 MARKETS - COMPETITIVE BENCHMARKING & COMPANY PROFILES
3.1 Competitive Benchmarking
3.1.1 Key Strategies and Developments
3.1.1.1 Funding Activities
3.1.1.2 New Offerings
3.1.1.3 Mergers and Acquisitions
3.1.1.4 Partnership, Collaboration, and Business Expansion
3.1.2 Market Share Analysis
3.1.3 Growth Share Analysis
3.1.3.1 By Application
3.1.3.2 By Omics Type
3.1.3.3 By Product Type
3.1.4 Visual Graphics of the Companies
3.1.5 Multi-Omics Ecosystem Active Players
3.2 Company Profiles
3.2.1 BGI Group
3.2.1.1 Company Overview
3.2.1.2 Role of BGI Group in the Single-Cell Multi-Omics Market
3.2.1.3 Financials
3.2.1.4 Analyst Perspective
3.2.2 Shilps Sciences
3.2.2.1 Company Overview
3.2.2.2 Role of Shilps Sciences in the Single-Cell Multi-Omics Market
3.2.2.3 Analyst Perspective
3.2.3 Takara Bio Inc.
3.2.3.1 Company Overview
3.2.3.2 Role of Takara Bio Inc. in the Single-Cell Multi-Omics Market
3.2.3.3 Financials
3.2.3.4 Analyst Perspective
Scope of the Study
Research Methodology
1 MARKET
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.2 Market Overview
1.2.1 Key Findings
1.2.2 Current Market Scenario
1.2.2.1 For Researchers
1.2.2.2 For Diagnostics
1.3 Industry Outlook
1.3.1 Regulatory Framework
1.3.2 Patent Analysis
1.3.2.1 Awaited Technological Developments
1.3.2.2 Patent Filing Trend (by Country)
1.3.2.3 Patent Filing Trend (by Year)
1.3.3 Key Trends
1.3.3.1 Advancements in Imaging Techniques for Single-Cell Sequencing
1.3.3.2 Use of Artificial Intelligence (AI) and Machine Learning (ML) in Single-Cell Multi-Omics
1.3.3.3 Increased Development of Advanced Solution Based on Single-Cell Technology
1.3.4 Opportunity Assessment
1.3.5 Product Benchmarking
1.3.6 Clinical Trials
1.4 COVID-19 Impact
1.4.1 Pre-COVID-19
1.4.2 During COVID-19
1.4.3 Post COVID-19
1.5 Business Dynamics
1.5.1 Impact Analysis
1.5.2 Business Drivers
1.5.2.1 Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (Sc-RNA)
1.5.2.2 Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
1.5.2.3 Increasing Use of Single-Cell Multi-Omics for Drug Development
1.5.2.4 Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics
1.5.3 Business Restraints
1.5.3.1 High Cost of Single-Cell Analysis and Sequencing
1.5.3.2 Limited Availability of Large Online Data Storage and Analysis Platforms
1.5.4 Business Opportunities
1.5.4.1 Expansion into New Research Applications, Such as Single-Cell Metabolomics
1.5.4.2 Increasing Adoption of Genomic-Based Medicine in Emerging Nations
2 SINGLE-CELL MULTI-OMICS MARKET (BY REGION)
2.1 Asia-Pacific
2.1.1 Key Findings and Opportunity Assessment
2.1.2 Market Dynamics
2.1.2.1 Impact Analysis
2.1.3 Sizing and Forecast Analysis
2.1.3.1 Asia-Pacific Single-Cell Multi-Omics Market (by Country)
2.1.3.1.1 China
2.1.3.1.2 Japan
2.1.3.1.3 India
2.1.3.1.4 Singapore
2.1.3.1.5 Australia
2.1.3.1.6 Rest-of-Asia-Pacific
3 MARKETS - COMPETITIVE BENCHMARKING & COMPANY PROFILES
3.1 Competitive Benchmarking
3.1.1 Key Strategies and Developments
3.1.1.1 Funding Activities
3.1.1.2 New Offerings
3.1.1.3 Mergers and Acquisitions
3.1.1.4 Partnership, Collaboration, and Business Expansion
3.1.2 Market Share Analysis
3.1.3 Growth Share Analysis
3.1.3.1 By Application
3.1.3.2 By Omics Type
3.1.3.3 By Product Type
3.1.4 Visual Graphics of the Companies
3.1.5 Multi-Omics Ecosystem Active Players
3.2 Company Profiles
3.2.1 BGI Group
3.2.1.1 Company Overview
3.2.1.2 Role of BGI Group in the Single-Cell Multi-Omics Market
3.2.1.3 Financials
3.2.1.4 Analyst Perspective
3.2.2 Shilps Sciences
3.2.2.1 Company Overview
3.2.2.2 Role of Shilps Sciences in the Single-Cell Multi-Omics Market
3.2.2.3 Analyst Perspective
3.2.3 Takara Bio Inc.
3.2.3.1 Company Overview
3.2.3.2 Role of Takara Bio Inc. in the Single-Cell Multi-Omics Market
3.2.3.3 Financials
3.2.3.4 Analyst Perspective
LIST OF FIGURES
Figure 1: An Overview of Single-Cell Multi-Omics Sequencing Technologies
Figure 2: Single-Cell Multi-Omics Market, Impact Analysis
Figure 3: Asia-Pacific Single-Cell Multi-Omics Market (by Application), % Share, 2022 and 2033
Figure 4: Single-Cell Multi-Omics Market: Research Methodology
Figure 5: Primary Research Methodology
Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 7: Top-Down Approach (Segment-Wise Analysis)
Figure 8: Single-Cell Multi-Omics Market, Patent Analysis (by Country), January 2018- March 2023
Figure 9: Single-Cell Multi-Omics Market, Patent Analysis (by Year), January 2018-December2022
Figure 10: Single-Cell Multi-Omics Market, Key Trends, Market Shift, 2022-2033
Figure 11: Single-Cell Multi-Omics Market, Impact Analysis
Figure 12: Data for Rare Diseases, 2020
Figure 13: Companies Using Multi-Omics Approach in Research and Development of Drugs and Vaccines
Figure 14: Advantages of Multi-Omics in Drug Discovery and Development
Figure 15: Cost of Single Cell Sequencing (by Company)
Figure 16: Some of the Advancements in Single-Cell Metabolomics
Figure 17: Single-Cell Multi-Omics Market Share (by Region)
Figure 18: Asia-Pacific Single-Cell Multi-Omics Market Incremental Revenue Opportunity (by Country), $Million, 2023-2033
Figure 19: Asia-Pacific Single-Cell Multi-Omics Market, $Billion, 2022-2033
Figure 20: Asia-Pacific Single-Cell Multi-Omics Market (by Country), % Share, 2022 and 2033
Figure 21: China Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 22: Japan Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 23: India Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 24: Singapore Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 25: Australia Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 26: Rest-of-Asia-Pacific Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 27: Single-Cell Multi-Omics Market, Number of Key Developments and Strategies, January 2018-March 2023
Figure 28: Funding Activities, January 2018-March 2023
Figure 29: New Offerings, January 2018-March 2023
Figure 30: Mergers and Acquisitions, January 2018-March 2023
Figure 31: Partnership, Collaboration, and Business expansion, January 2018-March 2023
Figure 32: Single-Cell Multi-Omics Market, Company Revenue Share Analysis, $Billion, 2022
Figure 33: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Application), 2023-2033
Figure 34: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Omics Type), 2023-2033
Figure 35: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Product Type), 2023-2033
Figure 36: Single Cell Multi Omics Market, Visual Graphics of the Companies
Figure 37: BGI Genomics.: Product Portfolio
Figure 38: BGI Genomics: Overall Financials, $Million, 2020-2022
Figure 39: Shilps Sciences: Product Portfolio
Figure 40: Takara Bio Inc.: Product Portfolio
Figure 41: Takara Bio Inc.: Overall Financials, $Million, 2020-2022
Figure 42: Takara Bio Inc.: Net Revenue (by Segment), $Million, 2020-2022
Figure 43: Takara Bio Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 44: Takara Bio Inc.: R&D Expenditure, $Million, 2020-2022
Figure 1: An Overview of Single-Cell Multi-Omics Sequencing Technologies
Figure 2: Single-Cell Multi-Omics Market, Impact Analysis
Figure 3: Asia-Pacific Single-Cell Multi-Omics Market (by Application), % Share, 2022 and 2033
Figure 4: Single-Cell Multi-Omics Market: Research Methodology
Figure 5: Primary Research Methodology
Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 7: Top-Down Approach (Segment-Wise Analysis)
Figure 8: Single-Cell Multi-Omics Market, Patent Analysis (by Country), January 2018- March 2023
Figure 9: Single-Cell Multi-Omics Market, Patent Analysis (by Year), January 2018-December2022
Figure 10: Single-Cell Multi-Omics Market, Key Trends, Market Shift, 2022-2033
Figure 11: Single-Cell Multi-Omics Market, Impact Analysis
Figure 12: Data for Rare Diseases, 2020
Figure 13: Companies Using Multi-Omics Approach in Research and Development of Drugs and Vaccines
Figure 14: Advantages of Multi-Omics in Drug Discovery and Development
Figure 15: Cost of Single Cell Sequencing (by Company)
Figure 16: Some of the Advancements in Single-Cell Metabolomics
Figure 17: Single-Cell Multi-Omics Market Share (by Region)
Figure 18: Asia-Pacific Single-Cell Multi-Omics Market Incremental Revenue Opportunity (by Country), $Million, 2023-2033
Figure 19: Asia-Pacific Single-Cell Multi-Omics Market, $Billion, 2022-2033
Figure 20: Asia-Pacific Single-Cell Multi-Omics Market (by Country), % Share, 2022 and 2033
Figure 21: China Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 22: Japan Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 23: India Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 24: Singapore Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 25: Australia Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 26: Rest-of-Asia-Pacific Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 27: Single-Cell Multi-Omics Market, Number of Key Developments and Strategies, January 2018-March 2023
Figure 28: Funding Activities, January 2018-March 2023
Figure 29: New Offerings, January 2018-March 2023
Figure 30: Mergers and Acquisitions, January 2018-March 2023
Figure 31: Partnership, Collaboration, and Business expansion, January 2018-March 2023
Figure 32: Single-Cell Multi-Omics Market, Company Revenue Share Analysis, $Billion, 2022
Figure 33: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Application), 2023-2033
Figure 34: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Omics Type), 2023-2033
Figure 35: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Product Type), 2023-2033
Figure 36: Single Cell Multi Omics Market, Visual Graphics of the Companies
Figure 37: BGI Genomics.: Product Portfolio
Figure 38: BGI Genomics: Overall Financials, $Million, 2020-2022
Figure 39: Shilps Sciences: Product Portfolio
Figure 40: Takara Bio Inc.: Product Portfolio
Figure 41: Takara Bio Inc.: Overall Financials, $Million, 2020-2022
Figure 42: Takara Bio Inc.: Net Revenue (by Segment), $Million, 2020-2022
Figure 43: Takara Bio Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 44: Takara Bio Inc.: R&D Expenditure, $Million, 2020-2022
LIST OF TABLES
Table 1: Single-Cell Multi-Omics Market, Key Developments Analysis, January 2018-March 2023
Table 2: Key Questions Answered in the Report
Table 3: Single-Cell Multi-Omics Market: Global Regulatory Organization
Table 4: Single-Cell Multi-Omics Market, Product Benchmarking
Table 5: Single-Cell Multi-Omics Market, Ongoing Clinical Trials
Table 6: Single-Cell Multi-Omics Platforms Used in the Diagnosis of Disease
Table 7: Recent Collaborations between Technology Providers and Life Sciences Companies
Table 8: Asia-Pacific Single-Cell Multi-Omics Market Dynamics, Impact Analysis
Table 9: Multi-Omics Ecosystem Active Players
Table 1: Single-Cell Multi-Omics Market, Key Developments Analysis, January 2018-March 2023
Table 2: Key Questions Answered in the Report
Table 3: Single-Cell Multi-Omics Market: Global Regulatory Organization
Table 4: Single-Cell Multi-Omics Market, Product Benchmarking
Table 5: Single-Cell Multi-Omics Market, Ongoing Clinical Trials
Table 6: Single-Cell Multi-Omics Platforms Used in the Diagnosis of Disease
Table 7: Recent Collaborations between Technology Providers and Life Sciences Companies
Table 8: Asia-Pacific Single-Cell Multi-Omics Market Dynamics, Impact Analysis
Table 9: Multi-Omics Ecosystem Active Players
